Recently, Miao et al. performed analysis on a model of squamous cell carcinoma treated with adoptive cytotoxic T cell transfer (ACT)-based immunotherapy, showing that TGF-β-responsive tumor-initiating stem cells are superior at resisting ACT (Miao et al., 2019). Here, TGFB1 is linked to neoplasm.